Does money bring happiness? A study by Professor Christian Bayer from the University of Bonn provides new answers to this often-discussed question. In the…
Leistungszentrum Elektroniksysteme (LZE) is a joint initiative of the Fraunhofer-Gesellschaft, its two Institutes Fraunhofer IIS and Fraunhofer IISB, and…
New powerful CPUs and panels for Sinumerik 840D sl
Shorter program runtimes, faster simulation
Larger memory and lower power consumption
A team of researchers from Berlin succeeded in an effort to fundamentally improve carbohydrate analysis. With the new method, developed by Kevin Pagel (Free…
As part of their research, the team of scientists headed by Dr. Larissa Schwarzkopf and Prof. Reiner Leidl from the Institute of Health Economics and Health…
In the digital age, data is becoming available in ever greater volumes, and the complexity of this data is increasing as well. At the same time, the number of…
Most of us think that farmers grow and harvest crops for food. That's true for many crops: they either feed humans or farm animals. However, there's another…
To treat children with a missing or under-developed ear, experienced surgeons harvest pieces of rib cartilage from the child and carve them into the framework…
Across Europe, increasing importance is being attached to issues related to the efficient delivery of primary healthcare in the context of sustainable…
Siemens has been awarded an order from Apex Clean Energy to supply, support installation and provide long-term service for 66 wind turbines for the Grant Wind…
DKFZ researchers identified nuclear receptor tailles (Tlx) as a valuable drug target for brain tumors especially gliobastomas. In vivo experiments showed almost doubling in survival time of mice harbouring brain tumors by inhibiting the expression of Tlx in tumor cells. In addition a highly significant correlation between expression of Tlx in brain tumor cells and survival of the patient was demonstrated.
6% of all prostate cancer patients die due to their illness. However, 80% of all prostate cancer patients do not need therapy, since their cancers grow slowly. Since the mainly used marker (prostate-specific antigen, PSA) is also elevated in case of inflammatory processes or with benign prostatic hyperplasia, DKFZ inventors analysed serum samples and identified miRNA-375 and miRNA-141 as new biomarkers for high-risk tumors.
Cachexia related to cancer, occurs in 30-70% of cancer patients and still represents an as-yet non-curable and fatal paraneoplastic syndrome in a variety of tumor entities. The present invention discloses a new method for preventing cancer cachexia based on preventing inhibition of the protein AMPK.
New software version 4.7 of the Sinumerik Operate user interface optimized for multitasking machine tools
Cross-technology, standardized look-and-feel for…
Using Raman spectroscopy and statistical analysis, the group succeeded in taking nanoscale measurements of the strain present at each pixel on the material's…
Genes may now be deleted without creating a scar in certain strains of Escherichia coli and other microorganisms, thanks to researchers at Agency for Science,…
Feedback
